Preparation method of N-methyl piperazine

The two-step reaction method of combining sodium borohydride reducing agent with glyoxal aqueous solution and N-methylethylenediamine under Lewis acid catalysis, the existing problems of poor safety and high cost in the preparation of N-methylpiperazine are solved. , high purity and high yield preparation, and the process is simple and environmentally friendly.

CN118978494AActive Publication Date: 2024-11-19CANGZHOU KANGZHUANG CHEM CO LTD

Patent Information

Application Number
CN202411038542.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-19
Estimated Expiration
2044-07-31

AI Technical Summary

Technical Problem

The existing N-methylpiperazine preparation methods have problems such as poor safety, high preparation cost and incomplete raw material conversion, especially the use of hydrogen and precious metal catalysts, accompanied by by-product generation.

Method used

The reaction of glyoxal aqueous solution and N-methylethylenediamine under Lewis acid catalyzed, and then treated with sodium borohydride as a reducing agent. N-methylpiperazine was prepared under mild conditions through two steps of reaction to avoid Use of added solvents and precious metal catalysts.

Benefits of technology

The preparation of N-methylpiperazine with high purity (98%) and high yield (95%) is achieved. It has simple process, environmentally friendly and has great application value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004973145490000011
    Figure BDA0004973145490000011
  • Figure BDA0004973145490000012
    Figure BDA0004973145490000012
  • Figure BDA0004973145490000013
    Figure BDA0004973145490000013
Patent Text Reader

Abstract

The invention relates to the technical field of fine chemicals, in particular to a preparation method of N-methyl piperazine. The preparation method of the N-methyl piperazine comprises the following steps: mixing a glyoxal aqueous solution and N-methyl ethylenediamine, then adding Lewis acid, mixing, and carrying out a first reaction to obtain a reaction solution; and mixing the reaction liquid with a reducing agent, and carrying out a second reaction to obtain the N-methyl piperazine. According to the method, N-methyl piperazine can be prepared under mild conditions by taking N-methyl ethylenediamine and glyoxal as raw materials, lewis acid as a catalyst and sodium borohydride as a reducing agent; the method has the advantages of simple operation, no need of additional solvents, high purity of the product after rectification, and high reaction yield of 95%, and the method has potential commercial value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of fine chemicals, and in particular to a method for preparing N-methylpiperazine. Background Art

[0002] N-Methylpiperazine (1-Methylpiperazine), CAS: 109-01-3, is an important organic amine that can be used as an intermediate for the manufacture of third- and fourth-generation quinolone antibacterial and anti-inflammatory drugs, anti-tuberculosis drugs, and the erectile dysfunction drug sildenafil. It can also be used as an intermediate for the preparation of plasticizers, resin hardeners, textile auxiliaries, and dyes.

[0003] There are four main methods for preparing N-methylpiperazine:

[0004] Method 1:

[0005]

[0006] Method 2:

[0007]

[0008] Method 3:

[0009]

[0010] Method 4:

[0011]

[0012] Patent document CN104364243B discloses a method (method one) for preparing N-methylpiperazine by catalytic dehydration with diethanolamine and methylamine under hydrogen atmosphere, which has high selectivity of N-methylpiperazine, but the required hydrogen pressure is too high, and there are certain safety issues. Patent document CN104557777B discloses a method (method two) for preparing N-methylpiperazine by catalytic reduction of N-methyliminodiacetonitrile under hydrogen atmosphere, which achieves high product selectivity (87%-93% yield), but still requires the use of Fe, Co, Ni, and even noble metal catalysts such as Ru and Rh. Patent document CN104496939B discloses a method (method three) for preparing N-methylpiperazine by catalytic hydrogenation reaction of dihydroxyethylpiperazine or hydroxyethylpiperazine under the action of a catalyst, and the selectivity of the main product piperazine, N-methylpiperazine, is less than 20%. Patent document CN101239957B discloses a method (method 4) for preparing N-methylpiperazine by reductive amination reaction of piperazine and formaldehyde. The reaction conditions of this method are mild, but there is a problem of incomplete conversion of raw materials.

[0013] The above methods all inevitably use hydrogen and metal catalysts and are accompanied by the problem of by-product generation. Summary of the invention

[0014] The purpose of the present invention is to provide a method for preparing N-methylpiperazine, so as to solve the problems of poor safety, high preparation cost and incomplete raw material conversion of the existing N-methylpiperazine.

[0015] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0016] The present invention provides a method for preparing N-methylpiperazine, comprising the following steps:

[0017] Mixing a glyoxal aqueous solution and N-methylethylenediamine, then adding Lewis acid (Lw) and mixing, performing a first reaction to obtain a reaction solution;

[0018] The reaction solution is mixed with a reducing agent and subjected to a second reaction to obtain N-methylpiperazine.

[0019] Preferably, in the above-mentioned method for preparing N-methylpiperazine, the molar ratio of glyoxal to N-methylethylenediamine in the glyoxal aqueous solution is 1.1:1 to 1:1.05;

[0020] The molar ratio of the Lewis acid to the glyoxal in the glyoxal aqueous solution is 0.01:1 to 0.1:1.

[0021] Preferably, in the above method for preparing N-methylpiperazine, the mass concentration of the glyoxal aqueous solution is 40%.

[0022] Preferably, in the above-mentioned method for preparing N-methylpiperazine, the Lewis acid is ZnCl2, FeCl3, AlCl3 or BF3.

[0023] Preferably, in the above-mentioned method for preparing N-methylpiperazine, the temperature of the first reaction is 25 to 30° C., and the time of the first reaction is 1 to 3 hours.

[0024] Preferably, in the above-mentioned method for preparing N-methylpiperazine, the reducing agent is NaBH4.

[0025] Preferably, in the above method for preparing N-methylpiperazine, the molar ratio of the reducing agent to glyoxal in the glyoxal aqueous solution is 1.2:1 to 1:1.

[0026] Preferably, in the above-mentioned method for preparing N-methylpiperazine, the temperature of the second reaction is 25 to 30° C., and the time of the second reaction is 5 to 8 hours.

[0027] The catalytic principle of the present invention is as follows:

[0028]

[0029] It can be seen from the above technical solution that compared with the prior art, the present invention has the following beneficial effects:

[0030] (1) The present invention uses N-methylethylenediamine and glyoxal as raw materials, Lewis acid (Lw) as a catalyst, and sodium borohydride as a reducing agent to prepare N-methylpiperazine under mild conditions (reaction temperature is 0-30° C.); no external solvent is required, and the obtained product has a high purity after rectification, which can reach 98%, and the reaction yield is high, which can be as high as 95%.

[0031] (2) The process of the present invention is simple, environmentally friendly, and has great application value. DETAILED DESCRIPTION

[0032] The present invention provides a method for preparing N-methylpiperazine, comprising the following steps:

[0033] Mixing a glyoxal aqueous solution and N-methylethylenediamine, then adding a Lewis acid and mixing, performing a first reaction, and obtaining a reaction solution;

[0034] The reaction solution is mixed with a reducing agent and subjected to a second reaction to obtain N-methylpiperazine.

[0035] In the present invention, the specific process of mixing the glyoxal aqueous solution and N-methylethylenediamine is: at 25-30° C., dropping the glyoxal aqueous solution into N-methylethylenediamine;

[0036] The dropping rate is preferably 85 to 100 g / hour, more preferably 90 to 98 g / hour, and even more preferably 92 to 95 g / hour.

[0037] In the present invention, the molar ratio of glyoxal to N-methylethylenediamine in the glyoxal aqueous solution is preferably 1.1:1 to 1:1.05, more preferably 1.1:1.01 to 1:1.03, and more preferably 1:1.

[0038] In the present invention, the molar ratio of the Lewis acid to glyoxal in the glyoxal aqueous solution is preferably 0.01:1 to 0.1:1, more preferably 0.02:1 to 0.07:1, and more preferably 0.05:1.

[0039] In the present invention, the mass concentration of the glyoxal aqueous solution is preferably 40%.

[0040] In the present invention, the Lewis acid is preferably ZnCl2, FeCl3, AlCl3 or BF3, more preferably ZnCl2, FeCl3 or AlCl3, and more preferably ZnCl2 or FeCl3.

[0041] In the present invention, the temperature of the first reaction is preferably 25 to 30° C., more preferably 26 to 29° C., and more preferably 27 to 28° C.; the time of the first reaction is preferably 1 to 3 h, more preferably 1 to 2.5 h, and more preferably 1 to 2 h.

[0042] In the present invention, the specific process of mixing the reaction solution with the reducing agent is:

[0043] The reaction solution is placed in an ice water bath, a reducing agent is added to the reaction solution in batches, and the temperature is naturally raised to the second reaction temperature;

[0044] The number of batches is preferably 8 to 12, more preferably 9 to 11, and more preferably 10;

[0045] The time interval between the batches is 12 to 20 minutes, more preferably 13 to 18 minutes, and even more preferably 15 minutes.

[0046] In the present invention, the reducing agent is preferably NaBH4.

[0047] In the present invention, the molar ratio of the reducing agent to glyoxal in the glyoxal aqueous solution is preferably 1.2:1 to 1:1, more preferably 1.1:1 to 1:1, and more preferably 1:1.

[0048] In the present invention, the temperature of the second reaction is preferably 25 to 30° C., more preferably 26 to 29° C., and more preferably 27 to 28° C.; the time of the second reaction is preferably 5 to 8 h, more preferably 5.5 to 7 h, and more preferably 6 to 6.5 h.

[0049] In the present invention, after the second reaction is completed, the method further comprises:

[0050] Add ethanol dropwise to the product obtained after the second reaction is completed, stir until no gas is released after the addition is completed, then distill to remove ethanol and water, filter and collect the filtrate, and rectify the filtrate;

[0051] The molar ratio of ethanol to NaBH4 is 3:1 to 4.1:1, more preferably 3.2:1 to 3.7:1, and more preferably 3.4:1 to 3.5:1;

[0052] The ethanol drop rate is 80 to 100 g / hour, more preferably 85 to 95 g / hour, and more preferably 90 to 92 g / hour;

[0053] The distillation temperature is preferably 80-100°C;

[0054] The distillation temperature is preferably 110-140°C.

[0055] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0056] Example 1

[0057] 100 g (1.35 mol) of N-methylethylenediamine was added to the reaction flask, and 196 g of a 40 wt% aqueous solution of glyoxal (1.35 mol of glyoxal) was added dropwise at 25°C while stirring. The addition was completed over 2 h. Then 1.84 g (13.5 mmol) of ZnCl2 was added to the reaction flask, and the reaction was continued at 25°C for 1 h. After the reaction was completed, the reaction flask was placed in an ice-water bath and the reaction flask was added in batches (6.1 g each time, with an interval of 15 min each time). Add 61g (1.61mol) NaBH4, naturally raise the temperature to 25°C, and continue the reaction for 6 hours; after the reaction, add 224g (4.86mol) ethanol dropwise to the reaction bottle, and complete the addition within 2.5 hours. Stir until no gas is precipitated, then distill off ethanol and water at 80-100°C, and collect the filtrate by filtration; the obtained filtrate is distilled at 110-140°C to obtain 121g colorless liquid N-methylpiperazine with a yield of 90% and a GC purity of 98%.

[0058] Example 2

[0059] 100 g (1.35 mol) of N-methylethylenediamine was added to the reaction flask, and 215 g of a 40 wt% aqueous solution of glyoxal (1.48 mol of glyoxal) was added dropwise at 25°C while stirring. The addition was completed over 2.5 h. Then 24 g (0.148 mol) of FeCl3 was added to the reaction flask, and the reaction was continued at 25°C for 1 h. After the reaction was completed, the reaction flask was placed in an ice-water bath, and the reaction flask was added in batches (6.1 g each time, with an interval of 15 min each time). Add 67g (1.77mol) NaBH4, naturally raise the temperature to 25°C, and continue the reaction for 6 hours; after the reaction, add 328g (7.12mol) ethanol dropwise to the reaction bottle, and add the mixture over 3.5h. Stir until no gas is precipitated, then distill off the ethanol and water at 80-100°C, and collect the filtrate by filtration; the filtrate obtained is distilled at 110-140°C to obtain 120g colorless liquid N-methylpiperazine with a yield of 89% and a GC purity of 98%.

[0060] Example 3

[0061] 100 g (1.35 mol) of N-methylethylenediamine was added to the reaction flask, and 196 g of a 40 wt% aqueous solution of glyoxal (1.35 mol of glyoxal) was added dropwise at 25°C while stirring. The addition was completed over 2 h. Then 8.6 g (64.5 mmol) of AlCl3 was added to the reaction flask, and the reaction was continued at 25°C for 1 h. After the reaction was completed, the reaction flask was placed in an ice-water bath, and the reaction flask was added in batches (6.1 g each time, with an interval of 15 min each time). Add 61g (1.61mol) NaBH4, naturally raise the temperature to 25°C, and continue the reaction for 6 hours; after the reaction, add 224g (4.86mol) ethanol dropwise to the reaction bottle, and complete the addition within 2.5 hours. Stir until no gas is precipitated, then distill off ethanol and water at 80-100°C, and collect the filtrate by filtration; the filtrate obtained is distilled at 110-140°C to obtain 118g of colorless liquid N-methylpiperazine, with a yield of 87% and a GC purity of 96%.

[0062] Example 4

[0063] 100 g (1.35 mol) of N-methylethylenediamine was added to the reaction flask, and 196 g of a 40 wt% aqueous solution of glyoxal (1.35 mol of glyoxal) was added dropwise at 25°C while stirring. The addition was completed over 2 h. Then 4.6 g (67.8 mmol) of BF3 was added to the reaction flask, and the reaction was continued at 25°C for 1 h. After the reaction was completed, the reaction flask was placed in an ice-water bath, and 6.1 g of the solution was added to the reaction flask in batches (15 min interval each time). Add 61g (1.61mol) NaBH4, naturally raise the temperature to 25℃, and continue the reaction for 6 hours; after the reaction, add 224g (4.86mol) ethanol dropwise to the reaction bottle, and add the mixture over 2.5h. Stir until no gas is precipitated, then distill off the ethanol and water at 80-100℃, and collect the filtrate by filtration; the filtrate obtained is distilled at 110-140℃ to obtain 121g colorless liquid N-methylpiperazine with a yield of 90% and a GC purity of 98%.

[0064] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A method for preparing N-methylpiperazine, characterized in that: The following steps are involved: Mixing a glyoxal aqueous solution and N-methylethylenediamine, then adding a Lewis acid and mixing, performing a first reaction, and obtaining a reaction solution; The reaction solution is mixed with a reducing agent and subjected to a second reaction to obtain N-methylpiperazine.

2. The method for preparing N-methylpiperazine according to claim 1, characterized in that: The molar ratio of glyoxal to N-methylethylenediamine in the glyoxal aqueous solution is 1.1:1 to 1:1.05; The molar ratio of the Lewis acid to the glyoxal in the glyoxal aqueous solution is 0.01:1 to 0.1:

1.

3. The method for preparing N-methylpiperazine according to claim 2, characterized in that: The mass concentration of the glyoxal aqueous solution is 40%.

4. The method for preparing N-methylpiperazine according to claim 3, characterized in that: The Lewis acid is ZnCl2, FeCl3, AlCl3 or BF3.

5. The method for preparing N-methylpiperazine according to claim 3 or 4, characterized in that: The temperature of the first reaction is 25-30° C., and the time of the first reaction is 1-3 hours.

6. The method for preparing N-methylpiperazine according to claim 5, characterized in that: The reducing agent is NaBH4.

7. The method for preparing N-methylpiperazine according to claim 6, characterized in that: The molar ratio of the reducing agent to the glyoxal in the glyoxal aqueous solution is 1.2:1 to 1:

1.

8. The method for preparing N-methylpiperazine according to claim 7, characterized in that: The temperature of the second reaction is 25-30° C., and the time of the second reaction is 5-8 hours.

Citation Information

Patent Citations

  • Method for preparing N-methyl piperazine

    CN114075152A

  • Sulfur dioxide removal from gas streams using hydroxyalkyl substituted piperazinones

    US4783327A

Cited By

  • Synthetic method for coproduction of piperazine and N-methyl piperazine and production device used in synthetic method

    CN122516924A

  • Process for the synthesis of piperazine co-product n-methylpiperazine and the production plant used

    CN122516924B